Chelidonine selectively inhibits the growth of gefitinib-resistant non-small cell lung cancer cells through the EGFR-AMPK pathway - ScienceDirect
Plausible mechanisms of action of miRNAs in the restoration of... | Download Scientific Diagram
Bufalin inhibits gefitinib resistant NCI-H460 human lung cancer cell migration and invasion in vitro - ScienceDirect
Mechanism of action of gefitinib. EGF = epidermal growth factor; EGFR =... | Download Scientific Diagram
Anti-EGFR Mechanism of Action: Antitumor Effect and Underlying Cause of Adverse Events
Mechanisms of action of EGFR inhibitors | EGFR Inhibitors in Cancer Treatment
Identification of gefitinib off-targets using a structure-based systems biology approach; their validation with reverse docking and retrospective data mining | Scientific Reports
Development of treatment options for Chinese patients with advanced sq | OTT
Action mechanism of epidermal growth factor receptor-tyrosine kinase... | Download Scientific Diagram
EGFR pathway and mechanism of action of osimertinib. Abbreviation:... | Download Scientific Diagram
Afatinib mechanism of action. Notes: From Hirsh, 45 with permission.... | Download Scientific Diagram
IJMS | Free Full-Text | Implications of MicroRNAs in the Treatment of Gefitinib-Resistant Non-Small Cell Lung Cancer | HTML
Frontiers | Targeting EGFR in Esophagogastric Cancer | Oncology
Mechanisms of cancer resistance to Gefitinib (Iressa). (a) HER1... | Download Scientific Diagram
Dacoplice® | Pfizer India | Mechanism of action
EGFR pathway and mechanism of action of osimertinib. Abbreviation:... | Download Scientific Diagram
![PDF] Efficacy and mechanism of action of the tyrosine kinase inhibitors gefitinib, lapatinib and neratinib in the treatment of HER2-positive breast cancer: preclinical and clinical evidence. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/8a326536a82985b639a71a821682a23fc08747e9/2-Figure1-1.png "PDF] Efficacy and mechanism of action of the tyrosine kinase inhibitors gefitinib, lapatinib and neratinib in the treatment of HER2-positive breast cancer: preclinical and clinical evidence. | Semantic Scholar")
PDF] Efficacy and mechanism of action of the tyrosine kinase inhibitors gefitinib, lapatinib and neratinib in the treatment of HER2-positive breast cancer: preclinical and clinical evidence. | Semantic Scholar
Mechanisms of resistance to irreversible epidermal growth factor receptor tyrosine kinase inhibitors and therapeutic strategies in non-small cell lung cancer | Oncotarget
Gefitinib - an overview | ScienceDirect Topics
Amivantamab: A Potent Novel EGFR/c-MET Bispecific Antibody Therapy for EGFR-mutated Non-small Cell Lung Cancer - touchONCOLOGY
Anti‐tumor activity of WK88‐1, a novel geldanamycin derivative, in gefitinib‐resistant non‐small cell lung cancers with Met amplification - Jang - 2014 - Cancer Science - Wiley Online Library
Treatment of Non–Small-Cell Lung Cancer with Erlotinib or Gefitinib | NEJM
The challenge of targeting EGFR: experience with gefitinib in nonsmall cell lung cancer | European Respiratory Society
Rationale and clinical basis for combining gefitinib (IRESSA, ZD1839) with radiation therapy for solid tumors - International Journal of Radiation Oncology, Biology, Physics
Posts tagged "gefitinib" - genglob magazine
